Lund University is celebrating 350 years. Read more on lunduniversity.lu.se

Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

LUDC-IRC Precision Medicine Symposium

Symposium
Type 2 diabetes and related conditions are rising rapidly around the global and conventional prevention and treatment strategies are failing to keep pace. Thus, new approaches, including those focused on patient-level biomarker data to optimize advice and therapies, have garnered tremendous interest; this is broadly termed “precision medicine”. The LUDC-IRC precision medicine symposium will bring together several outstanding international experts on precision medicine, along with junior and senior investigators from LUDC-IRC to describe and discuss cutting-edge research germane to this topic. Lectures will cover the tremendous opportunities offered through private-public partnerships; the major diabetes associations’ (ADA and EASD) perspectives; the interrogation of big data using state-of-the-art bioinformatics; translation of basic science to clinical practice; innovative trial designs; and the critical role of lifestyle in diabetes and malignancies.

Program

Welcome and overview

09-00-09-15 Paul Franks, LUDC  
Welcome                                                                                                                

Session 1: Precision medicine - Swedish, US and Europen perspectives

09:15-10:00 Maria Gomez, LUDC   
"The power of private-public partnerships in precision medicine"

10:00-10:45 Will Cefalu, American Diabetes Association, US 
"Revolutionizing diabetes management: emerging concepts for an individualized approach for Standards of Care”"

10:45-11:00 Coffe break

11:00-11:45 John Nolan, EASD  
"Towards personalized and precision care of diabetes in Europe"

11:45-12:00
Discussion

12:00-13:00 Lunch

Session 2: Genetic and non-genetic biomarkers in large population cohorts

13:00-13:30 Louise Brunkwall, LUDC

"The human gut microbiota and Metabolomics Malmö Offspring Study"

13:30-14:15 Ruth Loos, Icahn School of Medicine at Mount Sinai - New York City, US
"The genetics of obesity - From biology to precision medicine"

14:15-15:00
Discussion

15:00-15:15 Coffee break

Session 3: Innovative use of big data

15.15-15.45 Naeimeh Atabaki-Pasdar, LUDC
"Optimising NAFLD diagnosis by developing a prediction tool as a proxy to MRI scans applying machine learning approaches: A DIRECT study"

15:45-16:30 Manolis Dermitzakis, University of Geneva, Switzerland

"From oligarchy to democrady in the genome: the 98% non-coding fraction takes charge"

16:30-16:45
Discussion

Session 4: Precision medicine trials

16:45-17:15 Anders Rosengren, LUDC
"Genotype- and phenotypebased recall trials with type 2 diabetes patients"

17:15-17:45 Martin Ridderstråle, NovoNordisk, Denmark
"Combinations make perfect - academia and industry collaborations"

17:45-18:00
Discussion

18:00 Paul Franks, LUDC
Announcements

19:00-22:00
Dinner

Registration

For registering, please send an e-mail to Pernilla [dot] Siming [at] med [dot] lu [dot] se at the latest November12th clearly stating:

  • Participation with lunch
  • Participation with dinner
  • Any dietary requirements, if any

 

A no-show fee for SEK 500 if you register and do not show up

 

 

 

 

Time: 
30/11/2017 - 09:00 to 18:00
Location: 
Triangeln Scandic Hotel, Malmö
Contact: 
pernilla.siming [at] med.lu.se

About the event

Time: 
30/11/2017 - 09:00 to 18:00
Location: 
Triangeln Scandic Hotel, Malmö
Contact: 
pernilla.siming [at] med.lu.se

Lund University Diabetes Centre, CRC, SUS Malmö, Entrance 72, House 91:12. SE-205 02 Malmö. Telephone: +46 40 39 10 00